| Dr Jeffrey L Graziano, DPM | |
|
4660 Kenmore Ave Ste 608, Alexandria, VA 22304-1306 | |
| (703) 379-0700 | |
| Not Available |
| Full Name | Dr Jeffrey L Graziano |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 27 Years |
| Location | 4660 Kenmore Ave Ste 608, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255328423 | NPI | - | NPPES |
| 1255328423 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | 0103300846 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
| Loudoun Medical Group, Pc | 0042119661 | 280 |
News Archive
The Lewy Body Dementia Association and the Alzheimer's Drug Discovery Foundation have awarded $100,000 each to Omar El-Agnaf, PhD, of United Arab Amirates University and Michelle Mielke, PhD, of Mayo Clinic Rochester to provide one year of support for their research projects focused on developing indicators, or biomarkers, for dementia with Lewy bodies.
Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
Exposure to Agent Orange sprayed during the Vietnam War has been linked to increased levels of certain hormones in women and their breastfeeding children decades later, potentially putting them at higher risk of health problems, according to a new study in Science of the Total Environment.
› Verified 2 days ago
| Provider Name | Loudoun Medical Group, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407908817 PECOS PAC ID: 0042119661 Enrollment ID: O20040102000616 |
News Archive
The Lewy Body Dementia Association and the Alzheimer's Drug Discovery Foundation have awarded $100,000 each to Omar El-Agnaf, PhD, of United Arab Amirates University and Michelle Mielke, PhD, of Mayo Clinic Rochester to provide one year of support for their research projects focused on developing indicators, or biomarkers, for dementia with Lewy bodies.
Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
Exposure to Agent Orange sprayed during the Vietnam War has been linked to increased levels of certain hormones in women and their breastfeeding children decades later, potentially putting them at higher risk of health problems, according to a new study in Science of the Total Environment.
› Verified 2 days ago
| Provider Name | Abraham A Coster Dpm Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609966514 PECOS PAC ID: 8123095189 Enrollment ID: O20040910000665 |
News Archive
The Lewy Body Dementia Association and the Alzheimer's Drug Discovery Foundation have awarded $100,000 each to Omar El-Agnaf, PhD, of United Arab Amirates University and Michelle Mielke, PhD, of Mayo Clinic Rochester to provide one year of support for their research projects focused on developing indicators, or biomarkers, for dementia with Lewy bodies.
Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
Exposure to Agent Orange sprayed during the Vietnam War has been linked to increased levels of certain hormones in women and their breastfeeding children decades later, potentially putting them at higher risk of health problems, according to a new study in Science of the Total Environment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey L Graziano, DPM 224d Cornwall St Nw Ste 403, Leesburg, VA 20176-2704 Ph: (703) 737-6010 | Dr Jeffrey L Graziano, DPM 4660 Kenmore Ave Ste 608, Alexandria, VA 22304-1306 Ph: (703) 379-0700 |
News Archive
The Lewy Body Dementia Association and the Alzheimer's Drug Discovery Foundation have awarded $100,000 each to Omar El-Agnaf, PhD, of United Arab Amirates University and Michelle Mielke, PhD, of Mayo Clinic Rochester to provide one year of support for their research projects focused on developing indicators, or biomarkers, for dementia with Lewy bodies.
Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).
Rember—the blue dye that created a stir in 2008 when Phase 2 clinical trial data claimed that it slowed decline in people with Alzheimer's disease—has now been revamped for Phase 3 testing in another disease, behavioral-variant frontotemporal dementia (bvFTD).
Exposure to Agent Orange sprayed during the Vietnam War has been linked to increased levels of certain hormones in women and their breastfeeding children decades later, potentially putting them at higher risk of health problems, according to a new study in Science of the Total Environment.
› Verified 2 days ago
Virginia Hospital Center Physician Group - Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1600 N Beauregard St, Suite 300, Alexandria, VA 22311 Phone: 703-940-3810 Fax: 703-940-3811 | |
Leon G Shingledecker, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 8101 Hinson Farm Rd, Suite 301, Alexandria, VA 22306 Phone: 703-765-4321 | |
Landmark Foot And Ankle Center, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 5249 Duke St, #212, Alexandria, VA 22304 Phone: 703-370-2313 Fax: 703-370-2490 | |
Richard Lee, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2843 Duke St, Alexandria, VA 22314 Phone: 703-823-2357 Fax: 703-823-1572 | |
Soraia Refq, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4600 Kenmore Ave, Suite 608, Alexandria, VA 22304 Phone: 703-379-0700 Fax: 703-578-4161 | |
Leland T Gilmore, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8101 Hinson Farm Rd Ste 301, Alexandria, VA 22306 Phone: 703-560-3773 Fax: 703-799-0050 | |
Loudoun Medical Group, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6355 Walker Lane, Suite 503, Alexandria, VA 22310 Phone: 703-379-0700 Fax: 703-578-4161 |